Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular

Hideki Koizumi1, Tetsuya Yamagishi, Taizo Yamazaki

  • 1Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. hidekoiz@koto.kpu-m.ac.jp

Insights

Polypoidal choroidal vasculopathy (PCV) with choroidal vascular hyperpermeability is linked to bilateral membranes and poor ranibizumab response. These patients often have a history of central serous chorioretinopathy (CSC).

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Retinal Diseases

Background:

  • Polypoidal choroidal vasculopathy (PCV) is a subtype of age-related macular degeneration.
  • Choroidal vascular hyperpermeability is a key feature assessed via indocyanine green angiography (ICGA).
  • Understanding PCV characteristics is crucial for effective treatment strategies.

Purpose of the Study:

  • To determine the association between clinical features of PCV and choroidal vascular hyperpermeability.
  • To evaluate the relationship between hyperpermeability and patient history, clinical signs, and treatment outcomes.
  • To identify prognostic indicators in PCV patients.

Main Methods:

  • Retrospective analysis of 89 PCV patients' medical records and ICGA findings.
  • Evaluation of background factors, clinical manifestations, and response to intravitreal ranibizumab.
  • Statistical analysis to identify significant relationships (P-values reported).

Main Results:

  • Choroidal vascular hyperpermeability was present in 34.8% of PCV patients.
  • Hyperpermeability correlated with bilateral neovascular membranes (P=.009) and prior central serous chorioretinopathy (CSC) (P=.01).
  • Eyes with hyperpermeability showed increased subfoveal thickness (P < .001) and poorer response to ranibizumab (persistent fluid, P=.01).

Conclusions:

  • PCV patients with choroidal vascular hyperpermeability exhibit more bilateral neovascularization and a history of CSC.
  • These patients often present with thickened choroids and reduced treatment efficacy with ranibizumab.
  • Choroidal vascular hyperpermeability is a significant indicator of disease severity and treatment resistance in PCV.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...